Cilostazol attenuates on-treatment platelet reactivity in patients with CYP2C19 loss of function alleles receiving dual antiplatelet therapy: a genetic substudy of the CILON-T randomised controlled trial. (Q51501093)
Jump to navigation
Jump to search
scientific article published on 22 February 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cilostazol attenuates on-treatment platelet reactivity in patients with CYP2C19 loss of function alleles receiving dual antiplatelet therapy: a genetic substudy of the CILON-T randomised controlled trial. |
scientific article published on 22 February 2011 |
Statements
1 reference
Cilostazol attenuates on-treatment platelet reactivity in patients with CYP2C19 loss of function alleles receiving dual antiplatelet therapy: a genetic substudy of the CILON-T randomised controlled trial. (English)
1 reference
Young-Bae Park
1 reference
Byung-Hee Oh
1 reference
Kyung Woo Park
1 reference
Bon-Kwon Koo
1 reference
Jin Joo Park
1 reference
Jung-Won Suh
1 reference
Seung-Pyo Lee
1 reference
Il-Young Oh
1 reference
Han-Mo Yang
1 reference
Hae-Young Lee
1 reference
Hyun-Jae Kang
1 reference
Young-Suk Cho
1 reference
Tae-Jin Youn
1 reference
In-Ho Chae
1 reference
Dong-Ju Choi
1 reference
Hyo-Soo Kim
1 reference
22 February 2011
1 reference
1 reference
97
1 reference
8
1 reference
641-647
1 reference
Identifiers
1 reference